Skip to content

Study Evaluating the Efficacy of Joint Replacement

Assessment of Clinical Outcome Following Total Hip and Knee Replacement

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04691466
Acronym
SEVERE
Enrollment
1000
Registered
2020-12-31
Start date
2013-01-02
Completion date
2025-12-31
Last updated
2020-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Hip, Osteoarthritis, Knee

Keywords

Replacement, Arthroplasty, Patient-relevant outcome measure (PROM), KOOS, HOOS

Brief summary

Patient-related outcomes were originally designed to measure outcomes in clinical studies. They were not developed to predict outcomes, however, different studies showed close association between values achieved preoperatively and postoperative outcomes. The aim of the present trial is to identify patients with satisfactory and unsatisfactory outcomes after joint replacement and to investigate whether there are any potential predicting potential in preoperative results of the patient-related outcomes and if there exist other predicting factors for functional recovery or treatment failure after joint replacement surgery.

Interventions

PROCEDUREJoint replacement

Routinely performed hip- or knee replacement

Sponsors

Warmia and Mazury Oncology Centre
CollaboratorUNKNOWN
Nicolaus Copernicus University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients with primary or secondary hip- and knee osteoarthritis undergoing joint replacement surgery.

Exclusion criteria

1. An inability to understand the Polish language, 2. Presence of neuromuscular disease and cognitive impairment, 3. Having a prosthesis in another joint of the ipsilateral or contralateral lower limb placed within 6 months before the current surgery, 4. Having rheumatoid arthritis, 5. Symptoms in several joints (hip, knee or ankle) with expected total joint arthroplasty within 1 year.

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the patients' opinion about their hip. Change over time12 monthsChange between the following assessments as measured with the Hip disability and Osteoarthritis Outcome Score (HOOS) in patients undergoing total hip replacement; 0-100 points, worst to best; minimal clinical difference (MCD) = 10 points.
Assessment of the patients' opinion about their knee. Score change over time12 monthsChange between the following assessments as measured with the Knee injury and Osteoarthritis Outcome Score (KOOS) in patients undergoing total knee replacement; 0-100 points, worst to best; minimal clinical difference (MCD) = 10 points.

Secondary

MeasureTime frameDescription
Pain intensity. Change over time12 monthsMeasured with the Visual Analog Scale (VAS); 0-10 points, worst to best.
Range of motion.12 monthsAssessment of range of motion in hips and knees, respectively, in following assessments; degrees.
Hip abductors muscle strength. Change over time12 monthsDetermination of the Trendelenburg's sign in patients undergoing total hip replacement in following assessments; positive or negative.
Assessment of the quality of life. Score change over time12 monthsResults of the generic PROM, the Short Form Health Survey-36 (SF-36) in both, patients undergoing hip and knee replacement; 0-100 points, worst to best.

Other

MeasureTime frameDescription
Body mass index (BMI)12 monthsMeasurement of weight in kilograms and height in meters to combined to report BMI in kg/m\^2; to be measured twice, before intervention and after 12 months.
Activity12 monthsMeasured with the Tegner Activity Score (TAS); 1-10 points, worst to best; to be measured twice, before intervention and after 12 months.

Countries

Poland

Contacts

Primary ContactPrzemysław T Paradowski, MD, PhD
P.Paradowski@cm.umk.pl+48575908432
Backup ContactMarek K Gojło, MD, PhD
marekgojlo@gmail.com+48503084950

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026